Not FDA-approved (approved in some other countries)Porcine brain peptide preparationStrokedementia research
Cerebrolysin
Cerebrolysin is a mixture of low-molecular-weight peptides from pig brain, approved in some countries for stroke and dementia but not approved by the FDA.
What is Cerebrolysin?
Cerebrolysin is a mixture of low-molecular-weight peptides from pig brain, approved in some countries for stroke and dementia but not approved by the FDA. Cerebrolysin is not approved by the FDA (approved in some other countries); products sold online in the US are labeled for research use only.
Key takeaways
- Cerebrolysin is not approved by the FDA (approved in some other countries); products sold online in the US are labeled for research use only.
- PubMed indexes 638 papers on Cerebrolysin (89 tagged as clinical trials) as of October 19, 2026.
- ClinicalTrials.gov lists 43 registered studies using Cerebrolysin.
- 6 vendors in our directory listed Cerebrolysin in their public catalog on October 19, 2026.
Regulatory & access status
Cerebrolysin is not approved by the FDA (approved in some other countries); products sold online in the US are labeled for research use only.
Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.
How much research exists on Cerebrolysin?
PubMed indexes 638 papers mentioning Cerebrolysin in the title or abstract, 194 of them from the last five years and 89 tagged as clinical trials (search run October 19, 2026; repeat the search).
Most relevant recent papers
- Cerebrolysin for acute ischaemic stroke. — Cochrane Database Syst Rev, 2023 · review
- Cerebrolysin for vascular dementia. — Cochrane Database Syst Rev, 2019 · review
- Cerebrolysin for acute ischaemic stroke. — Cochrane Database Syst Rev, 2020 · review
- Cerebrolysin for acute ischaemic stroke. — Cochrane Database Syst Rev, 2017 · review
- Cerebrolysin for acute ischaemic stroke. — Cochrane Database Syst Rev, 2016 · review
- Cerebrolysin for acute ischaemic stroke. — Cochrane Database Syst Rev, 2015 · review
Registered clinical studies
ClinicalTrials.gov lists 43 studies with Cerebrolysin as an intervention (see all). Most recent:
- Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study — NCT07043686 · N/A · recruiting · started 2025-06-13
- Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Stroke — NCT02768571 · Phase 4 · completed · started 2016-03-14
- Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT) — NCT01822951 · Phase 4 · withdrawn
- Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage — NCT01787123 · Phase 2/Phase 3 · completed · started 2013-12-01
- Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia — NCT04830943 · Phase 3 · completed · started 2020-08-01
What the evidence does not show
- Paper counts measure research attention, not whether Cerebrolysin works or is safe.
- No FDA review of any "research use only" product's identity, purity, sterility or dose.
Research suppliers that list Cerebrolysin
6 vendors in our directory listed a product matching Cerebrolysin in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.
- Bulk Peptide Supply
- NuScience Peptides
- Pure Lab Peptides
- San Diego Peptides
- Southern Aminos
- Xcel Peptides
Prices per mg, where we could verify them, are on our price comparison.
Cerebrolysin reconstitution math
Lab arithmetic only, not dosing guidance: vial-by-vial concentration tables are on Cerebrolysin 60 mg vial math.
Cerebrolysin FAQ
Is Cerebrolysin FDA-approved?
Cerebrolysin is not approved by the FDA (approved in some other countries); products sold online in the US are labeled for research use only.
Is Cerebrolysin safe?
Safety data come from the published studies listed on this page; read them in full. Products sold as "research use only" have no FDA review of their purity, sterility or dose.
How much research is there on Cerebrolysin?
PubMed indexes 638 papers on Cerebrolysin (89 tagged as clinical trials) as of October 19, 2026.
Who sells Cerebrolysin?
Bulk Peptide Supply, NuScience Peptides, Pure Lab Peptides, San Diego Peptides, Southern Aminos, Xcel Peptides listed it on their public catalogs when we checked; a listing is not an endorsement.
Related compounds
OxytocinVIPDSIPSemaxSelankAdamaxDihexaPinealonAll cognitive, neuro & sleep